The association of the treatment with glucagon-like peptide-1 receptor agonist exenatide or insulin with cardiovascular outcomes in patients with type 2 diabetes: a retrospective observational study
1 Clinical Trials Biostatistics Unit, QIMR Berghofer Medical Research Institute, 300 Herston Road, Herston, Brisbane, 4006, QLD, Australia
2 Statistics Unit, QIMR Berghofer Medical Research Institute, Brisbane, Australia
3 Bristol-Myers Squibb, San Diego, CA, USA
4 University of Washington, Seattle, WA, USA